Correction of a dominant‐negative von Willebrand factor multimerization defect by small interfering RNA‐mediated allele‐specific inhibition of mutant von Willebrand factor
- 7 May 2018
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 16 (7) , 1357-1368
Abstract
No abstract availableKeywords
Funding Information
- Landsteiner Foundation for Blood Transfusion Research (1504)
This publication has 37 references indexed in Scilit:
- Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cellsBlood, 2013
- Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patientsJournal of Thrombosis and Haemostasis, 2012
- Endothelial von Willebrand factor regulates angiogenesisBlood, 2011
- The genetic basis of von Willebrand diseaseBlood Reviews, 2010
- Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease PatientsCurrent Biology, 2009
- Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand FactorJournal of Thrombosis and Haemostasis, 2006
- Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand diseaseThrombosis and Haemostasis, 2006
- Real-Time Imaging of the Dynamics and Secretory Behavior of Weibel-Palade BodiesArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Postoperative thrombocytopenia in type IIB von Willebrand diseaseAmerican Journal of Hematology, 1990
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977